Inhibition of Balb/c 3T3 cell transformation by synthetic acyclic retinoid NIK-333; possible involvement of enhanced gap junctional intercellular communication

Cancer Detection and Prevention

Volumn 31, Issue 4, 2007, Pages 332-338

  Tsujino, Takashi ^a,b   Nagata, Tomoya ^a   Katoh, Fumitaka ^a   Yamasaki, Hiroshi ^a  

^a KWANSEI GAKUIN UNIVERSITY   (Japan)

^b KYOTO KOKA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Chemoprevention; Connexins; Tumor promotion; Two stage carcinogenesis

Indexed keywords

3 METHYLCHOLANTHRENE; CONNEXIN 43; DYE; NIK 333; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOID; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CELL COMMUNICATION; CELL MEMBRANE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; GAP JUNCTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROINJECTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ANIMALS; BALB 3T3 CELLS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; CONNEXIN 43; GAP JUNCTIONS; MICE; RETINOIDS; TRETINOIN;

EID: 35248856449     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.06.001     Document Type: Article

References (33)

1. Hansen L.A., Sigman C.C., Andreola F., Ross S.A., Kelloff G.J., and De Luca L.M. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 21 7 (2000) 1271-1279
2. Kakizoe T. Chemoprevention of cancer-focusing on clinical trials. Jpn J Clin Oncol 33 9 (2003) 421-442
3. Moriwaki H. Prevention of liver cancer: basic and clinical aspects. Exp Mol Med 34 5 (2002) 319-325
4. Nishino H., Murakosh M., Ii T., Takemura M., Kuchide M., Kanazawa M., et al. Carotenoids in cancer chemoprevention. Cancer Metastasis Rev 21 3-4 (2002) 257-264
5. Altucci L., and Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 1 3 (2001) 181-193
6. Muto Y., Moriwaki H., and Omori M. In vitro binding affinity of novel synthetic polyprenoids (polyprenoic acids) to cellular retinoid-binding proteins. Gann 72 6 (1981) 974-977
7. Matsushima-Nishiwaki R., Okuno M., Takano Y., Kojima S., Friedman S.L., and Moriwaki H. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid. Carcinogenesis 24 8 (2003) 1353-1359
8. Suzui M., Masuda M., Lim J.T., Albanese C., Pestell R.G., and Weinstein I.B. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res 62 14 (2002) 3997-4006
9. Shimizu M., Suzui M., Deguchi A., Lim J.T., and Weinstein I.B. Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells. Clin Cancer Res 10 3 (2004) 1130-1140
10. Muto Y., Moriwaki H., Ninomiya M., Adachi S., Saito A., Takasaki K.T., et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 334 24 (1996) 1561-1567
11. Yamasaki H., and Katoh F. Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells. Cancer Res 48 12 (1988) 3490-3495
12. Kakunaga T, Yamasaki H, editors. Transformation assay of established cell lines: mechanisms and application. Proceedings of a workshop organized by IARC in collaboration with the US National Cancer Institute and the US Environmental Protection Agency, Lyon, 15-17 February 1984. Lyon: International Agency for Research on Cancer; 1985. (IARC Sci Publ 67).
13. Group INEW. Cellular and molecular mechanisms of cell transformation and standardization of transforming assays of established cell lines for the prediction of carcinogenic chemicals: overview and recommended protocols. Cancer Res 45 (1985) 2395-2399
14. Hirschi K.K., Xu C.E., Tsukamoto T., and Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 7 7 (1996) 861-870
15. Wilgenbus K.K., Kirkpatrick C.J., Knuechel R., Willecke K., and Traub O. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 51 4 (1992) 522-529
16. Yano T., Hernandez-Blazquez F.J., Omori Y., and Yamasaki H. Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32. Carcinogenesis 22 10 (2001) 1593-1600
17. Yamasaki H. Gap junctional intercellular communication and carcinogenesis. Carcinogenesis 11 7 (1990) 1051-1058
18. Kalimi G.H., Hampton L.L., Trosko J.E., Thorgeirsson S.S., and Huggett A.C. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raf/v-myc-transduced rat liver epithelial cell lines. Mol Carcinog 5 4 (1992) 301-310
19. Enomoto T., and Yamasaki H. Lack of intercellular communication between chemically transformed and surrounding nontransformed BALB/c 3T3 cells. Cancer Res 44 11 (1984) 5200-5203
20. Yamasaki H., Hollstein M., Mesnil M., Martel N., and Aguelon A.M. Selective lack of intercellular communication between transformed and nontransformed cells as a common property of chemical and oncogene transformation of BALB/c 3T3 cells. Cancer Res 47 21 (1987) 5658-5664
21. Krutovskikh V.A., Oyamada M., and Yamasaki H. Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: direct measurement of communication in vivo. Carcinogenesis 12 9 (1991) 1701-1706
22. Leder A., Kuo A., Cardiff R.D., Sinn E., and Leder P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 87 23 (1990) 9178-9182
23. Yamasaki H., and Enomoto T. Role of intercellular communication in BALB/c 3T3 cell transformation. Carcinog Compr Surv 9 (1985) 179-194
24. Kakunaga T. A quantitative system for assay of malignant transformation by chemical carcinogens using a clone derived from BALB-3T3. Int J Cancer 12 2 (1973) 463-473
25. Sakai A., and Sato M. Improvement of carcinogen identification in BALB/3T3 cell transformation by application of a 2-stage method. Mutat Res 214 2 (1989) 285-296
26. Esinduy C.B., Chang C.C., Trosko J.E., and Ruch R.J. In vitro growth inhibition of neoplastically transformed cells by non-transformed cells: requirement for gap junctional intercellular communication. Carcinogenesis 16 4 (1995) 915-921
27. Mehta P.P., Bertram J.S., and Loewenstein W.R. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44 1 (1986) 187-196
28. Budunova I.V., and Williams G.M. Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication. Cell Biol Toxicol 10 2 (1994) 71-116
29. Krutovskikh V.A., Mesnil M., Mazzoleni G., and Yamasaki H. Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins. Lab Invest 72 5 (1995) 571-577
30. Swierenga S.H., and Yamasaki H. Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity. IARC Sci Publ 116 (1992) 165-193
31. Katoh F., and Yamasaki H. Regulation of gap-junctional intercellular communication in transformation-sensitive and transformation-resistant BALB/c 3T3 cell variants. Carcinogenesis 12 10 (1991) 1923-1926
32. Yamasaki H. Aberrant expression and function of gap junctions during carcinogenesis. Environ Health Perspect 93 (1991) 191-197
33. Yamasaki H., Ashby J., Bignami M., Jongen W., Linnainmaa K., Newbold R.F., et al. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. Mutat Res 353 1-2 (1996) 47-63